MDCE (MDCE) Stock Price & Analysis
MDCE (MDCE) rose 0.00% to USD 0 as of June 10, 2026 at 13:03 UTC, according to Nexqual real-time market data.
MDCE last closed at USD 0; the session ranged USD 0–0 on volume of 11,010,000 shares. Market capitalization is $650,033, with a 52-week range of USD 0–0 (OID). Source: Nexqual, June 10, 2026 at 13:03 UTC.
Key Statistics (as of June 10, 2026 at 13:03 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 11,010,000 shares |
| Market Cap | $650,033 |
| Exchange | OID |
Technical Analysis (MDCE)
Nexqual's technical model rates MDCE "STRONG SELL" based on 0 bullish and 4 bearish signals across 124 daily candles, as of June 10, 2026 at 13:03 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 39.48 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (MDCE)
Wall Street analysts rate MDCE "None", per Nexqual as of June 10, 2026 at 13:03 UTC.
| Consensus Rating | None |
|---|
Earnings (MDCE)
Source: Nexqual, June 10, 2026 at 13:03 UTC.
Financials & Fundamentals (MDCE)
| Total Revenue | $1.07M |
|---|---|
| Gross Margin | +53.75% |
| Operating Margin | +35.36% |
| Profit Margin | +21.53% |
| ROE | +14.23% |
| Debt / Equity | 4.89 |
| Current Ratio | 70.69 |
| Total Cash | $147,843 |
| Total Debt | $67,674 |
| Free Cash Flow | $68,913 |
Source: Nexqual, June 10, 2026 at 13:03 UTC.
Financial Health Score (MDCE)
Nexqual rates MDCE's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 13:03 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — $148K cash, no debt |
| Cash Flow | Solid — FCF $69K, 6% margin |
| Efficiency | Mixed — ROE 14%, ROA 8.9% |
Ownership (MDCE)
| Shares Outstanding | 3.25B |
|---|
Source: Nexqual, June 10, 2026 at 13:03 UTC.
Leadership (MDCE)
MDCE is led by Marshall Perkins, CEO & President, per Nexqual as of June 10, 2026 at 13:03 UTC.
| CEO & President | Marshall Perkins |
|---|---|
| Principal Financial Officer, Principal Accounting Officer, Treasurer and Director | Hui Liu (age 55) |
| Chief Technology Officer and Director | Sean Lee-Heung (age 59) |
| Chief Marketing Officer and Director | Tang Ping (age 56) |
| COO, Chief Medical Officer & Director | Mark J. Langweiler DAAPM, DACFE, DC |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AVVH | AVVAA World Health Care Product | USD 0 | ▲ 0% |
| NSPT | Newron Sport | USD 0 | ▲ 0% |
| FBCD | FBC Holding, Inc. | USD 0 | ▲ 66.67% |
| GMZP | GEMZ Corp. | USD 0 | ▼ 66.67% |
| BRGO | Bergio International, Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 13:03 UTC. This page is informational and not investment advice.